Literature DB >> 10657057

Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents).

J B Calixto1.   

Abstract

This review highlights the current advances in knowledge about the safety, efficacy, quality control, marketing and regulatory aspects of botanical medicines. Phytotherapeutic agents are standardized herbal preparations consisting of complex mixtures of one or more plants which contain as active ingredients plant parts or plant material in the crude or processed state. A marked growth in the worldwide phytotherapeutic market has occurred over the last 15 years. For the European and USA markets alone, this will reach about $7 billion and $5 billion per annum, respectively, in 1999, and has thus attracted the interest of most large pharmaceutical companies. Insufficient data exist for most plants to guarantee their quality, efficacy and safety. The idea that herbal drugs are safe and free from side effects is false. Plants contain hundreds of constituents and some of them are very toxic, such as the most cytotoxic anti-cancer plant-derived drugs, digitalis and the pyrrolizidine alkaloids, etc. However, the adverse effects of phytotherapeutic agents are less frequent compared with synthetic drugs, but well-controlled clinical trials have now confirmed that such effects really exist. Several regulatory models for herbal medicines are currently available including prescription drugs, over-the-counter substances, traditional medicines and dietary supplements. Harmonization and improvement in the processes of regulation is needed, and the general tendency is to perpetuate the German Commission E experience, which combines scientific studies and traditional knowledge (monographs). Finally, the trend in the domestication, production and biotechnological studies and genetic improvement of medicinal plants, instead of the use of plants harvested in the wild, will offer great advantages, since it will be possible to obtain uniform and high quality raw materials which are fundamental to the efficacy and safety of herbal drugs.

Entities:  

Mesh:

Year:  2000        PMID: 10657057     DOI: 10.1590/s0100-879x2000000200004

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  117 in total

1.  Structure, control and regulation of the formal market for medicinal plants' products in Nigeria.

Authors:  Adegboyega E Oguntade; Isaac B Oluwalana
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-06-01

2.  Dynamics of medicinal plants knowledge and commerce in an urban ecosystem (Pernambuco, Northeast Brazil).

Authors:  Julio Marcelino Monteiro; Marcelo Alves Ramos; Elcida de Lima Araújo; Elba Lúcia Cavalcanti Amorim; Ulysses Paulino Albuquerque
Journal:  Environ Monit Assess       Date:  2010-09-21       Impact factor: 2.513

3.  Biochemical and toxicological studies of aqueous extract of Syzigium aromaticum (L.) Merr. & Perry (Myrtaceae) in rodents.

Authors:  E O Agbaje; A A Adeneye; A O Daramola
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-05-07

Review 4.  Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.

Authors:  Enoche F Oga; Shuichi Sekine; Yoshihisa Shitara; Toshiharu Horie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-04       Impact factor: 2.441

5.  The effects of long-term occupational exposure to dust from herbs.

Authors:  Marcin Golec
Journal:  Int Arch Occup Environ Health       Date:  2005-10-11       Impact factor: 3.015

6.  Influence of Brazilian herbal regulations on the use and conservation of native medicinal plants.

Authors:  Maria G L Brandão; Gustavo P Cosenza; Acácia M Stanislau; Geraldo W Fernandes
Journal:  Environ Monit Assess       Date:  2009-04-08       Impact factor: 2.513

7.  European legislation on herbal medicines: a look into the future.

Authors:  Gioacchino Calapai
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 8.  Clinical trials with herbal medicinal products in children: a literature analysis.

Authors:  Peter Marquardt; Karin Kaft; Karen Nieber
Journal:  Wien Med Wochenschr       Date:  2015-07-17

9.  Feasibility of UV-VIS-Fluorescence spectroscopy combined with pattern recognition techniques to authenticate a new category of plant food supplements.

Authors:  Raffaella Boggia; Federica Turrini; Marco Anselmo; Paola Zunin; Dario Donno; Gabriele L Beccaro
Journal:  J Food Sci Technol       Date:  2017-05-23       Impact factor: 2.701

10.  Didymin prevents hyperglycemia-induced human umbilical endothelial cells dysfunction and death.

Authors:  Kirtikar Shukla; Himangshu Sonowal; Ashish Saxena; Kota V Ramana
Journal:  Biochem Pharmacol       Date:  2018-03-14       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.